Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients
Clinical trial NCT05039190 · COMPLETED
Trial details
- NCT number
- NCT05039190
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-25
- Primary completion
- 2023-01-14
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.